Lifecore Biomedical (LFCR) Stock Statistics & Valuation Metrics

Lifecore Biomedical has a market cap or net worth of $258.07M. The enterprise value is ―.

Lifecore Biomedical has 37,025,330 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lifecore Biomedical’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is -3.94%.

The current PE Ratio of Lifecore Biomedical is 14.26. Lifecore Biomedical’s PEG ratio is 0.03.

In the last 12 months, Lifecore Biomedical had revenue of 128.26M and earned 12.01M in profits. Earnings per share was 0.39.

In the last 12 months, operating cash flow was 3.21M and capital expenditures -13.96M, giving a free cash flow of -10.74M billion.

Lifecore Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Lifecore Biomedical upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.

Lifecore Biomedical as a current ratio of 2.08, with Debt / Equity ratio of 5847.51%

In the past 12 months, Lifecore Biomedical has paid 183.00K in taxes.

Lifecore Biomedical EV to EBITDA ratio is 8.23, with an EV/FCF ratio of -16.16.

Lifecore Biomedical has $5.42M in cash and marketable securities with $130.34M in debt, giving a net cash position of $124.92M billion.

Gross margin is 33.45%, with operating margin of -6.90%, and net profit margin of 9.37%.

The average price target for Lifecore Biomedical is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy